Merck & Co. announced its Q3 Earnings Report.

Merck & Co. (MRK) announced its third-quarter earnings in Rahway, New Jersey. The company reported a total net income of $5.79 billion for the period.

The company reported earnings of $2.32 per share. Adjusted for one-time gains and costs, the earnings per share came in at $2.58. These results exceeded Wall Street expectations, surpassing the forecasted $2.36 earnings per share estimated by six analysts in a survey conducted by Zacks Investment Research.

The pharmaceutical manufacturer achieved total revenues of $17.28 billion for the quarter, also exceeding the anticipated $17.06 billion on the street. Merck expects earnings per share for 2023 to be between $8.93 and $8.98, with an annual revenue forecast ranging from $64.5 billion to $65 billion.